CLNN - Clene Inc

-

$undefined

N/A

(N/A)

Clene Inc NASDAQ:CLNN Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland.

Location: | Website: clene.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

42.12M

Cash

21.68M

Avg Qtr Burn

-6.843M

Short % of Float

3.32%

Insider Ownership

28.28%

Institutional Own.

13.11%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
CNM-Au8 Details
Multiple sclerosis

Phase 3

Initiation

CNM-Au8 Details
Amyotrophic lateral sclerosis

Phase 3

Initiation

CNM-Au8 Details
Amyotrophic lateral sclerosis

Phase 2

Update

CNM-Au8 Details
Multiple sclerosis

Phase 2

Update

CNM-Au8 Details
Parkinson's disease

Failed

Discontinued

Failed

Discontinued